+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Coagulation Factor Concentrates Market by Type of Coagulation Factor, Product Formulation, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887478
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Coagulation Factor Concentrates Market grew from USD 8.66 billion in 2023 to USD 8.84 billion in 2024. It is expected to continue growing at a CAGR of 7.46%, reaching USD 14.34 billion by 2030.

The coagulation factor concentrates market encompasses products used to treat bleeding disorders like hemophilia and von Willebrand disease. These concentrates are derived from plasma or recombinant technologies and are essential in medical settings to restore normal blood clotting processes. With the increasing prevalence of bleed-related conditions and a rise in the geriatric population, the necessity for coagulation factor concentrates is intensifying. The primary applications are in hospitals, clinics, and home care settings, with end-users being both patients with hereditary bleeding disorders and those with acquired deficiencies. Key growth influencers include technological advancements in recombinant DNA technology, increased awareness of therapies, and enhanced healthcare infrastructure, particularly in emerging economies. Also, the introduction of longer-acting therapies and personalized medicine approaches presents lucrative opportunities for manufacturers. However, the market faces limitations from high treatment costs, stringent regulatory frameworks, and the potential risks of viral transmissions from plasma-derived products. Challenges such as limited access in underdeveloped regions and the need for cold chain logistics add to the complexity. To foster innovation and business growth, research emphasis on developing cost-effective therapies, improving recombinant technologies, and enhancing production efficiency is crucial. Exploring gene therapy as an alternative treatment could also revolutionize market landscapes. Engagement in strategic collaborations and partnerships can help bridge gaps in distribution networks. The nature of the market is competitive yet promising, with significant opportunities in addressing unmet needs and expanding geographical footprints. Businesses aiming to capture market share should focus on value-based care models and patient-centric solutions to remain adaptable and resilient in the face of evolving healthcare paradigms.

Understanding Market Dynamics in the Coagulation Factor Concentrates Market

The Coagulation Factor Concentrates Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of hemophilia and clotting deficiencies
    • Increase in biotechnology R&D to develop effective coagulation factor concentrates
    • Inclination toward early diagnosis and treatment of diseases
  • Market Restraints
    • Contamination issues associated with the synthesis of coagulation factor concentrate
  • Market Opportunities
    • Introduction of improved coagulation factor concentrates
    • Significant advancements in gene therapy
  • Market Challenges
    • Stringent regulatory procedure for product approval

Exploring Porter’s Five Forces for the Coagulation Factor Concentrates Market

Porter’s Five Forces framework further strengthens the insights of the Coagulation Factor Concentrates Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Coagulation Factor Concentrates Market

External macro-environmental factors deeply influence the performance of the Coagulation Factor Concentrates Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Coagulation Factor Concentrates Market

The Coagulation Factor Concentrates Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Coagulation Factor Concentrates Market

The Coagulation Factor Concentrates Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Coagulation Factor Concentrates Market

The Coagulation Factor Concentrates Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Factor Concentrates Market, highlighting leading vendors and their innovative profiles. These include Bayer AG, Bio Products Laboratory Limited, BIOGEN INC., Biotest AG., Cerus Corporation, Emergent BioSolutions Inc., Kedrion S.p.A, LFB USA, Medscape Network, Novo Nordisk A/S, Octapharma USA, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Coagulation Factor Concentrates Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type of Coagulation Factor
    • Factor IX (FIX) concentrates
    • Factor VII (FVII) concentrates
    • Factor VIII (FVIII) concentrates
    • Factor XIII (FXIII) concentrates
  • Product Formulation
    • Plasma-Derived Coagulation Factor Concentrates
    • Recombinant Coagulation Factor Concentrates
  • Application
    • Hemophilia Treatment
    • Surgical Procedures
  • End-User
    • Homecare Settings
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of hemophilia and clotting deficiencies
5.1.1.2. Increase in biotechnology R&D to develop effective coagulation factor concentrates
5.1.1.3. Inclination toward early diagnosis and treatment of diseases
5.1.2. Restraints
5.1.2.1. Contamination issues associated with the synthesis of coagulation factor concentrate
5.1.3. Opportunities
5.1.3.1. Introduction of improved coagulation factor concentrates
5.1.3.2. Significant advancements in gene therapy
5.1.4. Challenges
5.1.4.1. Stringent regulatory procedure for product approval
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Coagulation Factor Concentrates Market, by Type of Coagulation Factor
6.1. Introduction
6.2. Factor IX (FIX) concentrates
6.3. Factor VII (FVII) concentrates
6.4. Factor VIII (FVIII) concentrates
6.5. Factor XIII (FXIII) concentrates
7. Coagulation Factor Concentrates Market, by Product Formulation
7.1. Introduction
7.2. Plasma-Derived Coagulation Factor Concentrates
7.3. Recombinant Coagulation Factor Concentrates
8. Coagulation Factor Concentrates Market, by Application
8.1. Introduction
8.2. Hemophilia Treatment
8.3. Surgical Procedures
9. Coagulation Factor Concentrates Market, by End-User
9.1. Introduction
9.2. Homecare Settings
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Coagulation Factor Concentrates Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Coagulation Factor Concentrates Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Coagulation Factor Concentrates Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. COAGULATION FACTOR CONCENTRATES MARKET RESEARCH PROCESS
FIGURE 2. COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2030 (%)
FIGURE 7. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. COAGULATION FACTOR CONCENTRATES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. COAGULATION FACTOR CONCENTRATES MARKET DYNAMICS
TABLE 7. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR IX (FIX) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR VII (FVII) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR VIII (FVIII) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY FACTOR XIII (FXIII) CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PLASMA-DERIVED COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY RECOMBINANT COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HEMOPHILIA TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 36. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 40. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 41. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 58. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 59. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 62. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 63. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 70. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 71. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 94. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 107. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 108. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. DENMARK COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 111. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 112. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 115. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 119. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 123. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 124. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 131. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 132. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 143. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 144. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 147. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 151. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 152. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 167. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 179. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 180. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY TYPE OF COAGULATION FACTOR, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY PRODUCT FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM COAGULATION FACTOR CONCENTRATES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. COAGULATION FACTOR CONCENTRATES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 191. COAGULATION FACTOR CONCENTRATES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Coagulation Factor Concentrates Market, which are profiled in this report, include:
  • Bayer AG
  • Bio Products Laboratory Limited
  • BIOGEN INC.
  • Biotest AG.
  • Cerus Corporation
  • Emergent BioSolutions Inc.
  • Kedrion S.p.A
  • LFB USA
  • Medscape Network
  • Novo Nordisk A/S
  • Octapharma USA, Inc.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information